Elevated levels of an enzyme called PHGDH in the blood of older adults could be an early warning sign of Alzheimer’s disease. Research led by UC San Diego has consistently found high levels of PHGDH expression in brain tissue and blood samples of older adults with different stages of the disease.
Unusual visual inspection of objects in infants may precede the development of the social symptoms characteristic of autism syndrome disorder, a UC Davis Health study has found.
A large international collaboration led by researchers from the Johns Hopkins Kimmel Cancer Center has identified promising new targets for pancreatic cancer treatment and early diagnosis after examining various aspects of these tumors’ genes and proteins.
With summer approaching and more and more people getting vaccinated for COVID-19, many San Diegans eagerly anticipate the season best known for outdoor activities. But with more time in the sun comes the need for sun-safe practices. During the pandemic,…
The risk of childhood leukemia among kids with Down syndrome is higher than predicted, according to a new study led by UC Davis and UC San Francisco researchers. Early diagnosis remains critical.
Research from scientists at St. Jude Children’s Research Hospital found mutations up to two years before cancer developed, showing an opportunity for early interventions.
A research team led by psychology and neuroscience professor Sylvie Belleville has just targeted an early biomarker of the disease.
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve Board of Governors found that Medicare beneficiaries who go on to be diagnosed with dementia are more likely to miss payments on bills as early as six years before a clinical diagnosis.
More than 30 Southwest Virginia residents on the University of Virginia Cancer Center Without Walls Community Advisory Board have set four regional priorities for cancer prevention and early detection. Their areas of focus are helping residents quit tobacco use, screenings for lung and colorectal cancer, along with efforts to prevent human papillomavirus (HPV), which causes several cancers.
Atlantic Health System is enrolling women in a landmark study that uses a simple blood test for the CA-125 protein to screen women who are at low risk for ovarian cancer. The purpose of the clinical trial is to help determine whether this test can catch ovarian cancer early in women who would not normally be screened for it. Atlantic Health System hospitals are the only centers in the New York metro region to participate in the study, and have the third highest enrollment numbers in the nation.
UC San Diego Health experts available to discuss these and related topics during Breast Cancer Awareness Month Mammography is the most effective tool for screening breast cancer, using X-rays to identify abnormalities in breast tissues. Although health care facilities saw…
In honor of Gynecologic Cancer Awareness Month, the Johns Hopkins Medicine Kelly Gynecologic Oncology Service is hosting a series of 60-minute webinars during which top experts will address important issues related to gynecologic cancers and survivorship.
Cleveland Clinic has joined the PATHFINDER Study, a prospective, multi-center clinical trial that is evaluating the clinical use of an investigational blood test that has the ability to detect more than 50 cancers across stages I-IV with a single blood…
UCAL researchers are developing a nanotechnology-enabled cancer diagnostic solution that will help detect early stage liver cancer for people who are at risk of developing the disease.